Should neurologists be trained to recognize and treat comorbid depression of neurologic disorders? Yes.
Depression is a relatively common psychiatric comorbidity of most neurological disorders, with prevalence rates ranging between 20 and 50% among patients with stroke, multiple sclerosis, epilepsy, Parkinson's disease and dementia. Furthermore, depression is an independent predictor of poor quality of life in these patients and has a negative impact on the response to treatment, course and recovery of neurological deficits. Thus, treatment of depression has become an integral part of the management of these neurologic disorders. This article discusses the rationale for neurologists to be trained in recognizing depressive disorders in neurologic patients and identifies the type of mood disorders in which neurologists can provide pharmacotherapy and those that need to be referred to the care of the psychiatrist.
Kanner
Andres M
AM
Department of Neurological Sciences, Rush Medical College, Rush Epilepsy Center and Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL, USA. akanner@rush.edu
D000818:Animals; D015897:Comorbidity; D003866:Depressive Disorder / Q000150:complications* / Q000453:epidemiology / Q000628:therapy*; D004503:Education, Medical, Graduate; D006801:Humans; D009422:Nervous System Diseases / Q000150:complications* / Q000453:epidemiology / Q000628:therapy*; D009462:Neurology / Q000193:education*